IRIS
GIACOMELLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 10.851
NA - Nord America 3.218
EU - Europa 1.568
SA - Sud America 172
AF - Africa 83
OC - Oceania 42
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 15.936
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 6.564
US - Stati Uniti d'America 3.062
HK - Hong Kong 2.058
CN - Cina 1.809
GB - Regno Unito 607
IT - Italia 271
DE - Germania 211
IN - India 129
BR - Brasile 120
CA - Canada 114
NL - Olanda 97
JP - Giappone 61
VN - Vietnam 56
TR - Turchia 48
UA - Ucraina 48
FR - Francia 46
ZA - Sudafrica 42
AU - Australia 39
PL - Polonia 39
MX - Messico 38
FI - Finlandia 35
ES - Italia 34
SE - Svezia 25
CZ - Repubblica Ceca 24
AT - Austria 20
ID - Indonesia 20
BD - Bangladesh 19
PT - Portogallo 18
AR - Argentina 15
EG - Egitto 13
CL - Cile 10
IL - Israele 10
CO - Colombia 9
EC - Ecuador 9
KZ - Kazakistan 9
LT - Lituania 9
RU - Federazione Russa 9
DK - Danimarca 8
SA - Arabia Saudita 8
BG - Bulgaria 7
CH - Svizzera 7
IR - Iran 7
PK - Pakistan 7
RO - Romania 7
EE - Estonia 5
GR - Grecia 5
JO - Giordania 5
MA - Marocco 5
SK - Slovacchia (Repubblica Slovacca) 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
IE - Irlanda 4
LU - Lussemburgo 4
PY - Paraguay 4
SN - Senegal 4
TH - Thailandia 4
GH - Ghana 3
IQ - Iraq 3
KR - Corea 3
KW - Kuwait 3
LB - Libano 3
OM - Oman 3
QA - Qatar 3
RS - Serbia 3
SI - Slovenia 3
TN - Tunisia 3
YT - Mayotte 3
AF - Afghanistan, Repubblica islamica di 2
BE - Belgio 2
BO - Bolivia 2
CY - Cipro 2
HU - Ungheria 2
IS - Islanda 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MK - Macedonia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PE - Perù 2
PH - Filippine 2
TW - Taiwan 2
ZM - Zambia 2
AQ - Antartide 1
AZ - Azerbaigian 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GN - Guinea 1
GY - Guiana 1
HR - Croazia 1
KE - Kenya 1
KH - Cambogia 1
LC - Santa Lucia 1
MD - Moldavia 1
MM - Myanmar 1
NC - Nuova Caledonia 1
RW - Ruanda 1
Totale 15.932
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.036
Hefei 1.100
Singapore 972
Ashburn 834
Boardman 616
London 525
Shanghai 348
Dallas 274
Council Bluffs 179
Beijing 170
Los Angeles 117
Pune 94
San Francisco 92
Amsterdam 71
Munich 61
Toronto 60
Rome 57
Washington 51
Seattle 48
Tokyo 44
Santa Clara 43
New York 38
Warsaw 32
Brooklyn 30
Ankara 25
Ho Chi Minh City 25
Montreal 23
Turku 23
Chicago 22
Stockholm 20
West Jordan 20
Brno 19
Boston 18
Johannesburg 18
São Paulo 18
Bari 17
Guangzhou 17
Manchester 15
Chennai 14
Jinan 14
Mexico City 14
Melbourne 13
Phoenix 13
Atlanta 12
Sydney 12
Charlotte 11
Helsinki 11
Naples 11
Paris 11
Qingdao 11
Barcelos 10
Secaucus 10
Hanover 9
Milan 9
Nuremberg 9
The Dalles 9
Canberra 8
Hangzhou 8
Cairo 7
Changsha 7
Frankfurt am Main 7
Jaguariúna 7
Madrid 7
Oklahoma City 7
Vienna 7
Hanoi 6
Las Vegas 6
St Louis 6
Xi'an 6
Amman 5
Andover 5
Bengaluru 5
Berlin 5
Biên Hòa 5
Bratislava 5
Brisbane 5
Central 5
Olomouc 5
Ottawa 5
Riyadh 5
Almaty 4
Athens 4
Bangkok 4
Bologna 4
Buenos Aires 4
Buffalo 4
Cape Town 4
Chaozhou 4
Da Nang 4
Dakar 4
Dhaka 4
Dublin 4
Guayaquil 4
Haikou 4
Jackson 4
Kansas City 4
Kongens Lyngby 4
Luxembourg 4
Markham 4
Nanjing 4
Totale 8.599
Salva come PNG Salva come JPEG
Nome #
------- 212
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 206
Fibroblast expression of CD248 may contribute to exacerbate microvascular damage during systemic sclerosis 204
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 198
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 196
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 189
Efficacy and safety of imatinib mesylate in systemic sclerosis. A systematic review and meta-analysis 182
AB0550 PHENOTYPE OF BIOPSY-PROVEN PATIENTS WITH PRIMARY SJÖGREN SYNDROME LACKING RO AUTOANTIBODIES: HIGH FREQUENCY OF DRYNESS SYMPTOMS WITH LOW SYSTEMIC ACTIVITY (BIG DATA SJÖGREN PROJECT) 180
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 179
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 169
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups 165
Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a “real-life” study 164
A comprehensive review on adult onset Still's disease 163
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort 163
Aberrant expression of IL-22RA1 on hematopoietic cells as immunologically signature of primary sjogren’s syndrome and sjogren-associated non-hodgkin lymphomas 160
AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS) 156
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 153
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 151
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 149
A3.1 Pathogenic role of IL-17 producing double negative (DN) T cells in primary sjögren’s syndrome 145
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 138
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 123
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19 115
Adult-onset Still's disease with elderly onset: results from a multicentre study 110
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 105
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 97
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 95
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 94
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 89
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 86
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 86
). IL-6 e TGF-b1 nel siero e nei sovranatanti di cellule mononucleate in pazienti con sclerosi sistemica (SSC). 84
Addressing the clinical unmet needs in primary Sjögren's Syndrome through the sharing, harmonization and federated analysis of 21 European cohorts 83
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis. 81
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 79
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 79
Activation antigens and adhesion molecules expression on Vd1+ T cells in systemic sclerosis (SSc) 78
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 77
EVIDENCE FOR REDUCED ANGIOGENESIS IN BONE MARROW (BM) IN SYSTEMIC SCLEROSIS (SSC) 77
Cytokine storm syndrome in severe COVID-19 77
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with Sjogren’s syndrome 76
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study 76
Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trial 74
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 73
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 72
Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data 69
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 68
Cardiovascular disease in primary sjögren’s syndrome 67
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 66
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 60
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 56
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 51
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort 50
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 46
The Vessels Contribute to Fibrosis in Systemic Sclerosis 46
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 46
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 44
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? 44
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis 44
The economic burden of fibromyalgia: A systematic literature review 43
Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis 42
EULAR Textbook on Rheumatic Diseases – Third Edition (2018) 42
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 41
The Effect of Ketogenic Diet on Inflammatory Arthritis and Cardiovascular Health in Rheumatic Conditions: A Mini Review 41
A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome 40
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 39
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 39
Development and implementation of the AIDA International Registry for patients with Behçet's disease 38
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 38
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 38
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 37
Sociodemographic factors in fibromyalgia: results from the Italian Fibromyalgia Registry 34
The evaluation of type I interferon score in dermatomyositis, a systematic review and a meta-analysis 34
Immunopharmacological profile of sebatic acid, a candidate for total parenteral nutrition. 34
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 33
Vitamin D and systemic lupus erythematosus - The hype and the hope 33
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 32
Potential of stem cells in the treatment of rheumatic disease 32
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis 32
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center 32
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 31
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 31
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart? 31
Autoimmune screening before adenovirus vector-based DNA vaccine in women may avoid underuse for all the subjects 31
Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases 30
Safety and efficacy of certolizumab pegol in a real-life cohort of patients with psoriasis and psoriatic arthritis 30
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 30
Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI). 30
Diagnosis of COVID-19 associated arthritis in patients with or without underlying rheumatic and musculoskeletal disease supported by musculoskeletal ultrasound: a case series from three European centres 29
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases 29
Assessment of health-related quality of life in patients with adult onset Still disease: Results from a multicentre cross-sectional study 29
Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms 29
IL-36α axis is modulated in patients with primary Sjogren's Syndrome. 29
Neoplasie e sistema immune 28
Laboratory assessment in patients with suspected rheumatic musculoskeletal diseases: challenges, pitfalls and perspectives 28
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 28
THU0582 Prognostic Factors of Macrophage Activation Syndrome in Adults: Analysis of 40 Cases in 2 Tertiary Referral Centers 28
The kaleidoscope of neurological manifestations in primary Sjögren's syndrome 28
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 28
Prevalence and characteristics of diffuse idiopathic skeletal hyperostosis (DISH) in Italy 27
Totale 7.823
Salva come PNG Salva come JPEG
Categoria #
all - tutte 186.789
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 186.789
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022648 0 5 29 4 7 2 4 4 55 29 19 490
2022/2023318 5 15 11 28 73 13 6 7 10 11 130 9
2023/20241.786 60 216 61 144 198 839 32 85 17 51 40 43
2024/202510.867 230 179 617 113 109 364 242 64 1.422 1.088 3.012 3.427
2025/20262.467 1.556 496 415 0 0 0 0 0 0 0 0 0
Totale 16.086